Tissue Intelligence Platform
See The Lesion.
Confirm It.
Sample It.
Real-time optical guidance for peripheral lung biopsy.
Two FDA 510(k) Clearances ┃ Live at Five Tier-1 Centers ┃ Key Patents Granted
THE CLINICAL GAP
Navigation gets you close. LIA™ confirms you are in the lesion.
Over 40% of peripheral lung biopsies fail on the first attempt. Not because physicians can't reach the lesion — but because they can't confirm they're in it.
The tools exist to navigate. What's missing is a view from the tip of the needle.
42%
of patients with lung cancer undergo more than one biopsy.
The last inch is where diagnosis is won or lost.
That's where LEADOPTIK works.
This is the kind of imaging we've needed in the periphery for years. LIA™ shows you what you're actually in.
Dr. Ali Sadoughi, MD
Director, Interventional Pulmonology and Bronchoscopy
Montefiore Einstein New York City
Built for the Lung Periphery. In Clinical Use Today.
FDA Cleared. Existing Reimbursement. In Use at Five Academic Medical Centers
